PHMR Consulting

Mark Ratcliffe co-founded phmr consulting in 2007. Prior to that he had 14 years' experience with major international pharmaceutical companies, in Health Economics, Pricing Reimbursement and Epidemiology roles - including as Group Director, Global Health Economics, Pricing, Reimbursement and Access Strategy for SmithKlineBeecham and Executive Director for PR&A and HE for EMEA region Eli Lilly. He led the pricing strategy and policy development for product launches across numerous therapy areas and has in-depth knowledge of international country pricing systems. He has worked closely with US, European and International markets on operational issues (e.g. PPRS, trade monitoring) and on the implementation of regional policies and strategies.

Prior to joining the pharmaceuticals industry he had a successful career in academia culminating in a Senior Research Fellow position at the London School of Economics. During his academic career Mark consulted extensively to the European Union and its various members states on health, pharmaceutical and Medtech policy. He has over 70 publications to his name and still writes regularly for the international financial and economic press on matters of welfare economics.

Mark has a PhD from the University of Hamburg in Mathematical Economics and Econometrics, an MSc from the London School of Economics in Health Planning and Financing Systems and a BSc in Economics from the University of London. Mark holds a Visiting Research Fellow position at the London School of Economics and teaches on the Master of Advanced Studies in Pharmaceutical Economics and Policy at the University of Lausanne.

Peter Hudson co-founded phmr consulting in 2007. Prior to that he had 25 years experience in academia and consulting. Peter was a founding member of the York Health Economics Consortium, the first health economics consultancy of its type in the world 25 years ago. YHEC provided economics consultancy on a global basis to virtually every department or ministry of health on health care policy and health care reform.

On leaving YHEC Peter established ph consulting, which retained a national government client base but expanded out to provide a Health Economics and Pricing and Reimbursement service to the Pharmaceutical and Medtech industry.

Peter has completed over 200 successful client projects in areas as diverse as global pricing and reimbursement strategy development, value proposition and pricing and reimbursement dossier development, price referencing and parallel trade modeling, forecasting, war gaming, scenario planning and pricing and reimbursement processes.